Evaluation of tumour hypoxia during radiotherapy using [18F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1619-7089
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Evaluation of tumour hypoxia during radiotherapy using [18F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer ; day:1 ; month:6 ; year:2016 ; pages:1-8
European journal of nuclear medicine and molecular imaging ; (1.6.2016), 1-8
- Creator
-
Zegers, Catharina M. L.
- Contributor
-
Hoebers, Frank J. P.
Elmpt, Wouter van
Bons, Judith A.
Öllers, Michel C.
Troost, Esther G. C.
Eekers, Daniëlle
Balmaekers, Leo
Arts-Pechtold, Marlies
Mottaghy, Felix M.
Lambin, Philippe
SpringerLink (Online service)
- DOI
-
10.1007/s00259-016-3429-y
- URN
-
urn:nbn:de:1111-2016060236053
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zegers, Catharina M. L.
- Hoebers, Frank J. P.
- Elmpt, Wouter van
- Bons, Judith A.
- Öllers, Michel C.
- Troost, Esther G. C.
- Eekers, Daniëlle
- Balmaekers, Leo
- Arts-Pechtold, Marlies
- Mottaghy, Felix M.
- Lambin, Philippe
- SpringerLink (Online service)
Other Objects (12)
![Evaluation of tumour hypoxia during radiotherapy using [18F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer](/assets/placeholder/searchResultMediaUnknown.png)
Evaluation of tumour hypoxia during radiotherapy using [18F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer
Repeatability of tumour hypoxia imaging using [18F]EF5 PET/CT in head and neck cancer
Precision Radiotherapy: 18F-FDG PET-based radiotherapy planning in Head and Neck cancers
18F-FMISO-PET hypoxia monitoring for head-and-neck cancer patients: radiomics analyses predict the outcome of chemo-radiotherapy
Hypoxia imaging with 18F-FAZA PET/CT predicts radiotherapy response in esophageal adenocarcinoma xenografts
Tumour hypoxia: molecular mechanisms and clinical implications
Spatio-temporal dynamics of hypoxia during radiotherapy
Interfering with Tumor Hypoxia for Radiotherapy Optimization
Total 18F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour
Effects of metformin on tumor hypoxia and radiotherapy efficacy: a [18F]HX4 PET imaging study in colorectal cancer xenografts
Do selective radiation dose escalation and tumour hypoxia status impact the loco-regional tumour control after radio-chemotherapy of head & neck tumours? The ESCALOX protocol
Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations
Evaluation of tumour hypoxia during radiotherapy using [18F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer
Repeatability of tumour hypoxia imaging using [18F]EF5 PET/CT in head and neck cancer
Precision Radiotherapy: 18F-FDG PET-based radiotherapy planning in Head and Neck cancers
18F-FMISO-PET hypoxia monitoring for head-and-neck cancer patients: radiomics analyses predict the outcome of chemo-radiotherapy
Hypoxia imaging with 18F-FAZA PET/CT predicts radiotherapy response in esophageal adenocarcinoma xenografts
Tumour hypoxia: molecular mechanisms and clinical implications
Spatio-temporal dynamics of hypoxia during radiotherapy
Interfering with Tumor Hypoxia for Radiotherapy Optimization
Total 18F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour
Effects of metformin on tumor hypoxia and radiotherapy efficacy: a [18F]HX4 PET imaging study in colorectal cancer xenografts
Do selective radiation dose escalation and tumour hypoxia status impact the loco-regional tumour control after radio-chemotherapy of head & neck tumours? The ESCALOX protocol
Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations
Evaluation of tumour hypoxia during radiotherapy using [18F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer
Repeatability of tumour hypoxia imaging using [18F]EF5 PET/CT in head and neck cancer
Precision Radiotherapy: 18F-FDG PET-based radiotherapy planning in Head and Neck cancers
18F-FMISO-PET hypoxia monitoring for head-and-neck cancer patients: radiomics analyses predict the outcome of chemo-radiotherapy
Hypoxia imaging with 18F-FAZA PET/CT predicts radiotherapy response in esophageal adenocarcinoma xenografts
Tumour hypoxia: molecular mechanisms and clinical implications
Spatio-temporal dynamics of hypoxia during radiotherapy
Interfering with Tumor Hypoxia for Radiotherapy Optimization
Total 18F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour
Effects of metformin on tumor hypoxia and radiotherapy efficacy: a [18F]HX4 PET imaging study in colorectal cancer xenografts
Do selective radiation dose escalation and tumour hypoxia status impact the loco-regional tumour control after radio-chemotherapy of head & neck tumours? The ESCALOX protocol